InvestorsHub Logo
Followers 3
Posts 1686
Boards Moderated 0
Alias Born 03/15/2018

Re: None

Thursday, 02/15/2024 8:24:27 AM

Thursday, February 15, 2024 8:24:27 AM

Post# of 34587
Wayne Boos reporting 480,000 shares owned at EOY - up 30,000 from Sept 30, '23.
https://ir.lexariabioscience.com/sec-filings/all-sec-filings##document-1915-0001235126-24-000010-2

(a) As of December 31, 2023, Wayne W. Boos beneficially owns
a total of 480,000 shares of the Companys Common Stock which
represent approximately 4.67078% of the outstanding Common Stock,
based on 10,276,641 Common Stock outstanding as of November 20, 2023,
as indicated by the Company. The percentage of Mr. Boos ownership of
Common Stock in the Company has varied since the filing of this
Schedule 13D as Mr. Boos has (i) purchased additional shares of the
Companys Common Stock, (ii) he has sold shares of the Companys
Common Stock, and (iii) the Company has issued additional shares of
Common Stock.

(b) Nature of Ownership. Wayne W. Boos has the sole power to
vote and direct the disposition of all of the 480,000 shares
reported as beneficially owned by him.

(c) Recent Transactions. In the 60 days prior to
December 31, 2023, Wayne W. Boos (i) sold 30,000 shares of the
Companys Common Stock for an average price per share of $1.31
and (ii) acquired 90,000 shares of the Companys Common Stock
for an average price per share of $1.405597 through his broker,
Merrill Lynch.

(d)No other person has the right to receive or the power to
direct the receipt of the dividends from, or proceeds from the
sale of, such securities.

(e) Wayne W. Boos ceased to be the beneficial owner of more than
five percent of the Companys Common Stock on or about
October 3, 2023, when the Company issued additional
shares of the Companys Common Stock.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LEXX News